Prof David Ritchie
Honorary (Professorial Fellow)
Department of Medicine
528 Scholarly works
13 Projects
HIGHLIGHTS
2026
Journal article
391.9: Real world efficacy of maribavir when used as pre-emptive therapy for cytomegalovirus reactivation in alloHCT patients who are intolerant, refractory or resistant.
DOI: 10.1097/01.tp.0001251488.91197.1c2026
Journal article
Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment
DOI: 10.1016/j.bneo.2026.1002602026
Journal article
Subtherapeutic posaconazole exposure during delayed-release tablet prophylaxis in high-risk patients with haematological malignancies: rationale for routine therapeutic drug monitoring
DOI: 10.1093/jac/dkag2332026
Journal article
Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.
DOI: 10.1182/blood.20260331562021
Research grants (ARC, NHMRC, MRFF)
Diagnosis, Discovery and Novel Phenotype Characterisation Using Multimodal Genomics in Patients With Inherited Bone Marrow Failure and Related Disorders
2021
Research grants (ARC, NHMRC, MRFF)
Repurposing BCL-2 Inhibitors for Immune Manipulation to Improve Outcomes in Allogeneic Stem Cell Transplantation
2018
Research Grant
Inhibiting BCL-2 and Nk Cells Improves Stem Cell Transplant Outcomes in Acute Myeloid Leukaemia
RECENT SCHOLARLY WORKS
2026
Journal article
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
DOI: 10.1038/s41409-026-02874-52026
Journal article
Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation
DOI: 10.3389/fimmu.2026.18790582026
Journal article
Identification of T:B Cell Multimers After Bispecific T Cell Engagement, Using Both Conventional and Imaging Flow Cytometry
DOI: 10.1002/cyto.a.700392026
Journal article
Who will watch the watchmen: unique challenges of T-cell redirecting therapies in T-cell malignancies
DOI: 10.1016/S2352-3026(26)00005-02026
Journal article
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
DOI: 10.1182/bloodadvances.20250166462026
Journal article
QuantiFERON-CMV Monitoring Post-Allogeneic Hematopoietic Stem Cell Transplantation Is Dynamic and Predictive of Immediate Cytomegalovirus Outcomes
DOI: 10.1111/tid.70152
RECENT PROJECTS
2026
Research contracts (non-grants)
Developing Translational Insights Into Poor Graft Function Following Allogeneic Stem Cell Transplantation
2025
Research grants (ARC, NHMRC, MRFF)
Personalised Haematopoietic Stem Cells, Moving Transplantation Into the 21st Century